NASDAQ
Edgewise Therapeutics, Inc. (EWTX) has a price/fcf ratio of -17.76x as of Monday, May 25, 2026. This represents a 18.69% decrease compared to its 12-month average of -14.97x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.